shortagewatch

Home / Anti-infectives / Immunoglobulins, Normal Human, for Extravascular Adm.

ATC J06BA01 · Immune Sera and Immunoglobulins

Immunoglobulins, Normal Human, for Extravascular Adm. shortage

As of 31 Oct 2026, Immunoglobulins, Normal Human, for Extravascular Adm. has a reported shortage in 2 of the 5 countries we track (Italy, Austria), covering 21 products.

Countries2/5
Products21packs or presentations
Short since25 Nov 20205.9 years ago
Earliest return31 Dec 2026company estimate
No return date15products
Main reasonIncreased demand
GermanyNo reported shortageItaly14 packs shortSpainNo reported shortageAustria7 packs shortBelgiumNo reported shortage

Timeline

ItalyAustria
20222023202420252026HYQVIAHYQVIAHYQVIAHYQVIAHYQVIAHYQVIAHYQVIAHYQVIAHYQVIAHYQVIACUVITRUCUVITRUCUVITRUCUVITRUCUVITRUCUVITRUCUTAQUIGCUTAQUIGCUTAQUIGCUTAQUIGCUTAQUIGCUTAQUIGCUTAQUIGCUTAQUIGHIZENTRAHIZENTRAHIZENTRAHIZENTRACuvitru 200 mg/ml Injektionslösung zur subkuCuvitru 200 mg/ml Injektionslösung zur subkutanen Anwendung, 1 x 10 mlCuvitru 200 mg/ml Injektionslösung zur subkuCuvitru 200 mg/ml Injektionslösung zur subkutanen Anwendung, 1 x 20 mlCuvitru 200 mg/ml Injektionslösung zur subkuCuvitru 200 mg/ml Injektionslösung zur subkutanen Anwendung, 1 x 40 mlCuvitru 200 mg/ml Injektionslösung zur subkuCuvitru 200 mg/ml Injektionslösung zur subkutanen Anwendung, 10 x 10 mlCuvitru 200 mg/ml Injektionslösung zur subkuCuvitru 200 mg/ml Injektionslösung zur subkutanen Anwendung, 10 x 20 mlCuvitru 200 mg/ml Injektionslösung zur subkuCuvitru 200 mg/ml Injektionslösung zur subkutanen Anwendung, 30 x 10 mlCuvitru 200 mg/ml Injektionslösung zur subkuCuvitru 200 mg/ml Injektionslösung zur subkutanen Anwendung, 5 x 40 mltoday

Solid bars run from the reported start to today; faded bars show the time left until the expected return. An arrow means no return date was given.

Affected products

CountryProductHolderSinceExpected backReason
ITHYQVIABAXALTA INNOVATIONS GMBH16 Jun 2021not givenIncreased demand
Elevata richiesta: forniture discontinue
ITHYQVIABAXALTA INNOVATIONS GMBH1 Oct 2021not givenIncreased demand
Elevata richiesta: forniture discontinue
ITHYQVIABAXALTA INNOVATIONS GMBH8 Nov 2021not givenIncreased demand
Elevata richiesta: forniture discontinue
ITHYQVIABAXALTA INNOVATIONS GMBH15 Dec 2021not givenIncreased demand
Elevata richiesta: forniture discontinue
ITHYQVIABAXALTA INNOVATIONS GMBH31 Oct 2022not givenIncreased demand
Elevata richiesta: forniture discontinue
ITCUVITRUBAXALTA INNOVATIONS GMBH1 Apr 2025not givenDistribution or logistics
Ridotta disponibilità per forniture discontinue: distribuzione contingentata
ITCUVITRUBAXALTA INNOVATIONS GMBH1 Apr 2025not givenDistribution or logistics
Ridotta disponibilità per forniture discontinue: distribuzione contingentata
ITCUVITRUBAXALTA INNOVATIONS GMBH1 Apr 2025not givenDistribution or logistics
Ridotta disponibilità per forniture discontinue: distribuzione contingentata
ITCUTAQUIGOCTAPHARMA ITALY S.P.A.10 Mar 202631 Dec 2026Increased demand
Elevata richiesta: forniture discontinue
ITCUTAQUIGOCTAPHARMA ITALY S.P.A.10 Mar 202631 Dec 2026Increased demand
Elevata richiesta: forniture discontinue
ITCUTAQUIGOCTAPHARMA ITALY S.P.A.10 Mar 202631 Dec 2026Increased demand
Elevata richiesta: forniture discontinue
ITCUTAQUIGOCTAPHARMA ITALY S.P.A.10 Mar 202631 Dec 2026Increased demand
Elevata richiesta: forniture discontinue
ITHIZENTRACSL BEHRING GMBH6 Jul 202631 Dec 2026Increased demand
Elevata richiesta: distribuzione contingentata
ITHIZENTRACSL BEHRING GMBH6 Jul 202631 Dec 2026Increased demand
Elevata richiesta: distribuzione contingentata
ATCuvitru 200 mg/ml Injektionslösung zur subkutanen Anwendung, 1 x 10 mlBaxalta Innovations GmbH25 Nov 2020not givenActive ingredient shortage
Verknappung des Wirkstoffes
ATCuvitru 200 mg/ml Injektionslösung zur subkutanen Anwendung, 1 x 20 mlBaxalta Innovations GmbH25 Nov 2020not givenActive ingredient shortage
Verknappung des Wirkstoffes
ATCuvitru 200 mg/ml Injektionslösung zur subkutanen Anwendung, 1 x 40 mlBaxalta Innovations GmbH25 Nov 2020not givenActive ingredient shortage
Verknappung des Wirkstoffes
ATCuvitru 200 mg/ml Injektionslösung zur subkutanen Anwendung, 10 x 10 mlBaxalta Innovations GmbH25 Nov 2020not givenActive ingredient shortage
Verknappung des Wirkstoffes
ATCuvitru 200 mg/ml Injektionslösung zur subkutanen Anwendung, 10 x 20 mlBaxalta Innovations GmbH25 Nov 2020not givenActive ingredient shortage
Verknappung des Wirkstoffes
ATCuvitru 200 mg/ml Injektionslösung zur subkutanen Anwendung, 30 x 10 mlBaxalta Innovations GmbH25 Nov 2020not givenActive ingredient shortage
Verknappung des Wirkstoffes
ATCuvitru 200 mg/ml Injektionslösung zur subkutanen Anwendung, 5 x 40 mlBaxalta Innovations GmbH25 Nov 2020not givenActive ingredient shortage
Verknappung des Wirkstoffes

"Expected back" is the date the company gave the authority, when it gave one. Ask a pharmacist about alternatives.

Related medicines also in short supply

Immunoglobulins, Normal Human, for Intravascular Adm.